Entrepreneurship Goes Global: ResMeds Gamble Harvard Case Solution & Analysis

Based on its innovative medical devices for the treatment of sleep apnea, CEO Peter Farrell, ResMed has made Australian born of a successful global company. But the company is trying to implement a strategy of expansion unit from its core oriented market a much broader market for people suffering from stroke and congestive heart failure, an approach that involves a completely different business model to sell GM products through new channels. This problem is exacerbated by the organization in which key resources R & D and production are located in Australia, while the main markets are in the United States and Europe. To conclude the event, Farrell must decide what action to take on several fronts. Strategically, it must decide whether to continue the implementation of the five-year initiative to expand the market, organizational, it must decide whether the locus of the initiative should be moved from Australia to Germany, the most promising market for stroke and CHF applications and management, he has to decide how to deal with the management team that struggled with this new initiative so long. "Hide
by Christopher A. Bartlett, Andrey N. McLean, Meg Wo┼║ny Source: Harvard Business School 24 pages. Publication Date: April 26, 2004. Prod. #: 304051-PDF-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.